HIV in pregnancy: Mother-to-child transmission, pharmacotherapy, and toxicity
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
HIV in pregnancy: Mother-to-child transmission, pharmacotherapy, and toxicity
Authors
Keywords
HIV, Antiretroviral therapy, Mother-to-child transmission, Placental membrane transporters, Placental/fetal development, Fetal programming
Journal
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
Volume 1867, Issue 10, Pages 166206
Publisher
Elsevier BV
Online
2021-06-29
DOI
10.1016/j.bbadis.2021.166206
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Role of Elevated SFLT‐1 on the Regulation of Placental Transporters in Women With Pre‐Eclampsia
- (2020) Dea Kojovic et al. CTS-Clinical and Translational Science
- Therapeutic drug monitoring of HIV antiretroviral drugs in pregnancy
- (2020) Brendan O’Kelly et al. THERAPEUTIC DRUG MONITORING
- Serotonin homeostasis in the materno‐foetal interface at term: Role of transporters (SERT/SLC6A4 and OCT3/SLC22A3) and monoamine oxidase A (MAO‐A) in uptake and degradation of serotonin by human and rat term placenta
- (2020) Rona Karahoda et al. Acta Physiologica
- Advances in Long-Acting Agents for the Treatment of HIV Infection
- (2020) Aadia I. Rana et al. DRUGS
- Pharmacokinetics of HIV therapies in pregnant patients: an update
- (2020) Megan Neary et al. Expert Opinion on Drug Metabolism & Toxicology
- Darunavir Pharmacokinetics With an Increased Dose During Pregnancy
- (2020) Ahizechukwu C. Eke et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Placental growth disorders and perinatal adverse outcomes in Brazilian HIV-infected pregnant women
- (2020) Helena Lucia Barroso dos Reis et al. PLoS One
- Endogenous Retroviral Envelope Syncytin Induces HIV-1 Spreading and Establishes HIV Reservoirs in Placenta
- (2020) Yuyang Tang et al. Cell Reports
- Raltegravir versus efavirenz in antiretroviral-naive pregnant women living with HIV (NICHD P1081): an open-label, randomised, controlled, phase 4 trial
- (2020) Esaú C João et al. Lancet HIV
- Integrating the prevention of mother-to-child transmission of HIV into primary healthcare services after AIDS denialism in South Africa: perspectives of experts and health care workers - a qualitative study
- (2020) Jean Claude Mutabazi et al. BMC HEALTH SERVICES RESEARCH
- Innovative Approaches for Pharmacology Studies in Pregnant and Lactating Women: A Viewpoint and Lessons from HIV
- (2020) Ahizechukwu C. Eke et al. CLINICAL PHARMACOKINETICS
- Periconceptional exposure to lopinavir, but not darunavir, impairs decidualization: a potential mechanism leading to poor birth outcomes in HIV-positive pregnancies
- (2020) Smriti Kala et al. HUMAN REPRODUCTION
- Pharmacokinetics of tenofovir alafenamide with and without cobicistat in pregnant and postpartum women living with HIV
- (2020) Kristina M. Brooks et al. AIDS
- Neurodevelopmental and behavioral consequences of perinatal exposure to the HIV drug efavirenz in a rodent model
- (2019) Lisa van de Wijer et al. Translational Psychiatry
- Epidemiology of Perinatal HIV Transmission in the United States in the Era of Its Elimination
- (2019) Steven R. Nesheim et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- A comparison of metabolic outcomes between obese HIV-exposed uninfected youth from the PHACS SMARTT Study and HIV-unexposed youth from the NHANES Study in the U.S.
- (2019) Jennifer Jao et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Implementing prevention policies for mother-to-child transmission of HIV in rural Malawi, South Africa and United Republic of Tanzania, 2013–2016
- (2019) Harriet Jones et al. BULLETIN OF THE WORLD HEALTH ORGANIZATION
- Long-Acting Injectable Antiretroviral Treatment Acceptability and Preferences: A Qualitative Study Among US Providers, Adults Living with HIV, and Parents of Youth Living with HIV
- (2019) Jane M. Simoni et al. AIDS PATIENT CARE AND STDS
- Cobicistat-containing antiretroviral regimens are not recommended during pregnancy
- (2019) Sarita D. Boyd et al. AIDS
- In Utero Efavirenz Exposure and Neurodevelopmental Outcomes in HIV-exposed Uninfected Children in Botswana
- (2019) Adam R. Cassidy et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- The inhibitory effect of antiretroviral drugs on the L-carnitine uptake in human placenta
- (2019) Rona Karahoda et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Multiple Drug Transporters Contribute to the Placental Transfer of Emtricitabine
- (2019) Qingquan Zeng et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Children exposed or unexposed to HIV: weight, height and BMI during the first five years of life. A Danish Nationwide Cohort Study
- (2019) Ellen Moseholm et al. CLINICAL INFECTIOUS DISEASES
- INTERACTIONS BETWEEN MARAVIROC AND THE ABCB1, ABCG2 AND ABCC2 TRANSPORTERS: AN IMPORTANT ROLE IN TRANSPLACENTAL PHARMACOKINETICS
- (2019) Lenka Tupova et al. DRUG METABOLISM AND DISPOSITION
- Neural-Tube Defects and Antiretroviral Treatment Regimens in Botswana
- (2019) Rebecca Zash et al. NEW ENGLAND JOURNAL OF MEDICINE
- Physiologically Based Pharmacokinetic Models to Predict Maternal Pharmacokinetics and Fetal Exposure to Emtricitabine and Acyclovir
- (2019) Xiaomei I. Liu et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Evaluating Neurodevelopmental Consequences of Perinatal Exposure to Antiretroviral Drugs: Current Challenges and New Approaches
- (2019) Jordan G. Schnoll et al. Journal of Neuroimmune Pharmacology
- Inclusion of pregnant women in antiretroviral drug research: what is needed to move forwards?
- (2019) Lee Fairlie et al. Journal of the International AIDS Society
- Safety and pharmacokinetics of dolutegravir in pregnant mothers with HIV infection and their neonates: A randomised trial (DolPHIN-1 study)
- (2019) Catriona Waitt et al. PLOS MEDICINE
- Growth and Neurodevelopment of HIV-Exposed Uninfected Children: a Conceptual Framework
- (2019) Catherine J. Wedderburn et al. Current HIV/AIDS Reports
- Association of maternal antiretroviral use with microcephaly in children who are HIV-exposed but uninfected (SMARTT): a prospective cohort study
- (2019) Paige L Williams et al. Lancet HIV
- Mini review: Prevention of mother–child transmission of HIV: 25 years of continuous progress toward the eradication of pediatric AIDS?
- (2019) Stéphane Blanche Virulence
- Dolutegravir pharmacokinetics in pregnant and postpartum women living with HIV
- (2018) Nikki Mulligan et al. AIDS
- Pharmacokinetic Changes during Pregnancy According to Genetic Variants: a Prospective Study in HIV-Infected Patients Receiving Atazanavir-Ritonavir
- (2018) Emanuele Focà et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics of Efavirenz 400 mg Once Daily During Pregnancy and Post-Partum
- (2018) Mohammed Lamorde et al. CLINICAL INFECTIOUS DISEASES
- Pharmacokinetics of HIV-Integrase Inhibitors During Pregnancy: Mechanisms, Clinical Implications and Knowledge Gaps
- (2018) Ruben van der Galiën et al. CLINICAL PHARMACOKINETICS
- An update on expression and function of p-gp/abcb1 and bcrp/abcg2 in the placenta and fetus
- (2018) Lyrialle W. Han et al. Expert Opinion on Drug Metabolism & Toxicology
- Pharmacokinetics of Tenofovir Alafenamide When Coadministered With Other HIV Antiretrovirals
- (2018) Rebecca Begley et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Current antiviral drugs and their analysis in biological materials – Part II: Antivirals against hepatitis and HIV viruses
- (2018) Lucie Nováková et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Current antiviral drugs and their analysis in biological materials—Part I: Antivirals against respiratory and herpes viruses
- (2018) Lucie Nováková et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Expression of Concentrative Nucleoside Transporters (SLC28A) in the Human Placenta: Effects of Gestation Age and Prototype Differentiation-Affecting Agents
- (2018) Lucie Jiraskova et al. MOLECULAR PHARMACEUTICS
- Interactions of protease inhibitors atazanavir and ritonavir with ABCB1, ABCG2, and ABCC2 transporters: Effect on transplacental disposition in rats
- (2018) Lukas Cerveny et al. REPRODUCTIVE TOXICOLOGY
- Immune Dysfunction and Coinfection with Human Immunodeficiency Virus and Schistosoma japonicum in Yi People
- (2018) Yu Yang et al. Journal of Immunology Research
- Elvitegravir/cobicistat pharmacokinetics in pregnant and postpartum women with HIV
- (2018) Jeremiah D. Momper et al. AIDS
- Equilibrative nucleoside transporter 1 (ENT1, SLC29A1) facilitates transfer of the antiretroviral drug abacavir across the placenta
- (2018) Lukas Cerveny et al. DRUG METABOLISM AND DISPOSITION
- Trophoblast – the central unit of fetal growth, protection and programming
- (2018) Frantisek Staud et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Placental structure in preterm birth amongst HIV positive versus negative women in Kenya
- (2018) Moses M. Obimbo et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Neural-Tube Defects with Dolutegravir Treatment from the Time of Conception
- (2018) Rebecca Zash et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ibalizumab in Multidrug-Resistant HIV — Accepting Uncertainty
- (2018) Virginia Sheikh et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase 3 Study of Ibalizumab for Multidrug-Resistant HIV-1
- (2018) Brinda Emu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efavirenz reduces renal excretion of lamivudine in rats by inhibiting organic cation transporters (OCT, Oct) and multidrug and toxin extrusion proteins (MATE, Mate)
- (2018) Martina Ceckova et al. PLoS One
- Perinatal HIV Service Coordination: Closing Gaps in the HIV Care Continuum for Pregnant Women and Eliminating Perinatal HIV Transmission in the United States
- (2018) Mary-Margaret Andrews et al. PUBLIC HEALTH REPORTS
- Tenofovir Exposure during Pregnancy and Postpartum in Women Receiving Tenofovir Disoproxil Fumarate for the Prevention of Mother-to-Child Transmission of Hepatitis B Virus
- (2018) Tim R. Cressey et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Placental Cytomegalovirus Infection
- (2018) Kaleigh Lindholm et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Interest of Youth Living with HIV in Long-Acting Antiretrovirals
- (2018) Ethel D. Weld et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- HIV Glasgow 2018, 28-31 October 2018, Glasgow, UK
- (2018) Journal of the International AIDS Society
- Evaluating darunavir/ritonavir dosing regimens for HIV-positive pregnant women using semi-mechanistic pharmacokinetic modelling
- (2018) Stein Schalkwijk et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Longitudinal HIV Care Trajectories in North Carolina
- (2017) Kimberly A. Powers et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Brief Report
- (2017) José R. Arribas et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Antiretroviral unbound concentration during pregnancy: piece of interest in the puzzle?
- (2017) D. Metsu et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial
- (2017) David A Margolis et al. LANCET
- Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection (GS-US-380–1490): a randomised, double-blind, multicentre, phase 3, non-inferiority trial
- (2017) Paul E Sax et al. LANCET
- Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection (GS-US-380-1489): a double-blind, multicentre, phase 3, randomised controlled non-inferiority trial
- (2017) Joel Gallant et al. LANCET
- Role of nucleoside transporters in transplacental pharmacokinetics of nucleoside reverse transcriptase inhibitors zidovudine and emtricitabine
- (2017) S. Karbanova et al. PLACENTA
- Breast milk and in utero transmission of HIV-1 select for envelope variants with unique molecular signatures
- (2017) Kyle J. Nakamura et al. Retrovirology
- Placental pathology in HIV infection at term: a comparison with HIV-uninfected women
- (2017) Emma Kalk et al. TROPICAL MEDICINE & INTERNATIONAL HEALTH
- Antiretroviral therapy in pregnant women living with HIV: a clinical practice guideline
- (2017) Reed A C Siemieniuk et al. BMJ-British Medical Journal
- Antiretroviral therapy in pregnant women living with HIV: a clinical practice guideline
- (2017) Reed A C Siemieniuk et al. BMJ-British Medical Journal
- Role of HIV exposure and infection in relation to neonatal GBS disease and rectovaginal GBS carriage: a systematic review and meta-analysis
- (2017) Piet Cools et al. Scientific Reports
- Long-Term Effects of In Utero Antiretroviral Exposure: Systolic and Diastolic Function in HIV-Exposed Uninfected Youth
- (2016) Vitor Guerra et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Role of ABC and Solute Carrier Transporters in the Placental Transport of Lamivudine
- (2016) Martina Ceckova et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Role of ABCB1, ABCG2, ABCC2 and ABCC5 transporters in placental passage of zidovudine
- (2016) Zuzana Neumanova et al. BIOPHARMACEUTICS & DRUG DISPOSITION
- Prenatal exposure to zidovudine and risk for ventricular septal defects and congenital heart defects: data from the Antiretroviral Pregnancy Registry
- (2016) Vani Vannappagari et al. European Journal of Obstetrics & Gynecology and Reproductive Biology
- Pharmacokinetics of Total and Unbound Etravirine in HIV-1–Infected Pregnant Women
- (2016) Moti Ramgopal et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- P-glycoprotein (ABCB1) activity decreases raltegravir disposition in primary CD4+P-gphighcells and correlates with HIV-1 viral load
- (2016) Gerard Minuesa et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Long-term administration of tenofovir or emtricitabine to pregnant rats; effect onAbcb1a,Abcb1bandAbcg2expression in the placenta and in maternal and fetal organs
- (2016) Lukas Cerveny et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Molecular mechanisms of serotonergic action of the HIV-1 antiretroviral efavirenz
- (2016) Dhwanil A. Dalwadi et al. PHARMACOLOGICAL RESEARCH
- Etravirine inhibits ABCG2 drug transporter and affects transplacental passage of tenofovir disoproxil fumarate
- (2016) Josef Reznicek et al. PLACENTA
- Impact of HIV-1 infection on the feto-maternal crosstalk and consequences for pregnancy outcome and infant health
- (2016) Marcus Altfeld et al. Seminars in Immunopathology
- Cuba Validated as the First Country to Eliminate Mother-to-Child Transmission of Human Immunodeficiency Virus and Congenital Syphilis
- (2016) Sonja Caffe et al. SEXUALLY TRANSMITTED DISEASES
- Emtricitabine is a substrate of MATE1 but not of OCT1, OCT2, P-gp, BCRP or MRP2 transporters
- (2016) Josef Reznicek et al. XENOBIOTICA
- Pregnancy-Associated Changes in Pharmacokinetics: A Systematic Review
- (2016) Gali Pariente et al. PLOS MEDICINE
- Etravirine Pharmacokinetics in HIV-Infected Pregnant Women
- (2016) Nikki Mulligan et al. Frontiers in Pharmacology
- Perinatal outcomes associated with maternal HIV infection: a systematic review and meta-analysis
- (2016) Chrystelle O O Wedi et al. Lancet HIV
- Effects of Antiviral Drugs on Organic Anion Transport in Human Placental BeWo Cells
- (2015) Tomohiro Nabekura et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- No Need for Lopinavir Dose Adjustment during Pregnancy: a Population Pharmacokinetic and Exposure-Response Analysis in Pregnant and Nonpregnant HIV-Infected Subjects
- (2015) Ahmed Hamed Salem et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Raltegravir Permeability across Blood-Tissue Barriers and the Potential Role of Drug Efflux Transporters
- (2015) M. Tozammel Hoque et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Physiologically-based pharmacokinetic modeling of renally excreted antiretroviral drugs in pregnant women
- (2015) Maïlys De Sousa Mendes et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Maraviroc Pharmacokinetics in HIV-1–Infected Pregnant Women
- (2015) Angela Colbers et al. CLINICAL INFECTIOUS DISEASES
- In Utero Exposure to Zidovudine and Heart Anomalies in the ANRS French Perinatal Cohort and the Nested PRIMEVA Randomized Trial
- (2015) Jeanne Sibiude et al. CLINICAL INFECTIOUS DISEASES
- Raltegravir in HIV-1–Infected Pregnant Women: Pharmacokinetics, Safety, and Efficacy
- (2015) Maren I. Blonk et al. CLINICAL INFECTIOUS DISEASES
- Central Nervous System Penetration of Antiretroviral Drugs: Pharmacokinetic, Pharmacodynamic and Pharmacogenomic Considerations
- (2015) Eric H. Decloedt et al. CLINICAL PHARMACOKINETICS
- Physiologically Based Modelling of Darunavir/Ritonavir Pharmacokinetics During Pregnancy
- (2015) Angela Colbers et al. CLINICAL PHARMACOKINETICS
- Regulation of drug transporter expression and function in the placenta
- (2015) Frantisek Staud et al. Expert Opinion on Drug Metabolism & Toxicology
- Prevention of mother-to-child transmission of HIV Type 1: the role of neonatal and infant prophylaxis
- (2015) Stacey A Hurst et al. Expert Review of Anti-Infective Therapy
- Cancer Among Children With Perinatal Exposure to HIV and Antiretroviral Medications—New Jersey, 1995–2010
- (2015) Wade Ivy et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Pharmacokinetics of Once Versus Twice Daily Darunavir in Pregnant HIV-Infected Women
- (2015) Alice Stek et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Efficacy and safety of efavirenz 400 mg daily versus 600 mg daily: 96-week data from the randomised, double-blind, placebo-controlled, non-inferiority ENCORE1 study
- (2015) LANCET INFECTIOUS DISEASES
- Effect of drug efflux transporters on placental transport of antiretroviral agent abacavir
- (2015) Zuzana Neumanova et al. REPRODUCTIVE TOXICOLOGY
- Congenital Anomalies and In Utero Antiretroviral Exposure in Human Immunodeficiency Virus–Exposed Uninfected Infants
- (2015) Paige L. Williams et al. JAMA Pediatrics
- Safety of efavirenz in the first trimester of pregnancy
- (2014) Nathan Ford et al. AIDS
- Placental Transfer of Darunavir in anEx VivoHuman Cotyledon Perfusion Model
- (2014) Laurent Mandelbrot et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Population Pharmacokinetics of Abacavir in Pregnant Women
- (2014) Floris Fauchet et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Atazanavir exposure is effective during pregnancy, regardless of tenofovir use
- (2014) Angela Colbers et al. ANTIVIRAL THERAPY
- Protecting the Fetus Against HIV Infection: A Systematic Review of Placental Transfer of Antiretrovirals
- (2014) Shelley A. McCormack et al. CLINICAL PHARMACOKINETICS
- Raltegravir Pharmacokinetics in Neonates Following Maternal Dosing
- (2014) Diana F. Clarke et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Raltegravir Pharmacokinetics During Pregnancy
- (2014) D. Heather Watts et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Pharmacokinetics of total and unbound darunavir in HIV-1-infected pregnant women*
- (2014) Angela Colbers et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- First Trimester Exposure to Antiretroviral Therapy and Risk of Birth Defects
- (2014) Kelesitse Phiri et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Preterm Birth: Now the Leading Cause of Child Death Worldwide
- (2014) J. E. Lawn et al. Science Translational Medicine
- Pharmacokinetics, safety and transplacental passage of rilpivirine in pregnancy
- (2013) Angela Colbers et al. AIDS
- Interactions of tenofovir and tenofovir disoproxil fumarate with drug efflux transporters ABCB1, ABCG2, and ABCC2; role in transport across the placenta
- (2013) Zuzana Neumanova et al. AIDS
- Raltegravir Has a Low Propensity To Cause Clinical Drug Interactions through Inhibition of Major Drug Transporters: anIn VitroEvaluation
- (2013) Matthew L. Rizk et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Role of P-glycoprotein in the efflux of raltegravir from human intestinal cells and CD4+ T-cells as an interaction target for anti-HIV agents
- (2013) Yumi Hashiguchi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Organic Cation Transporter 3 (OCT3/SLC22A3) and Multidrug and Toxin Extrusion 1 (MATE1/SLC47A1) Transporter in the Placenta and Fetal Tissues: Expression Profile and Fetus Protective Role at Different Stages of Gestation1
- (2013) Davoud Ahmadimoghaddam et al. BIOLOGY OF REPRODUCTION
- HIV-exposed uninfected children: a growing population with a vulnerable immune system?
- (2013) L. Afran et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Total and unbound darunavir pharmacokinetics in pregnant women infected with HIV-1: results of a study of darunavir/ritonavir 600/100 mg administered twice daily
- (2013) CD Zorrilla et al. HIV MEDICINE
- Multidrug and toxin extrusion proteins (MATE/SLC47); role in pharmacokinetics
- (2013) Frantisek Staud et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Pharmacokinetics of an Increased Atazanavir Dose With and Without Tenofovir During the Third Trimester of Pregnancy
- (2013) Regis Kreitchmann et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Transplacental passage of etravirine and maraviroc in a multidrug-experienced HIV-infected woman failing on darunavir-based HAART in late pregnancy
- (2013) A. Calcagno et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Transfer of metformin across the rat placenta is mediated by organic cation transporter 3 (OCT3/SLC22A3) and multidrug and toxin extrusion 1 (MATE1/SLC47A1) protein
- (2013) Davoud Ahmadimoghaddam et al. REPRODUCTIVE TOXICOLOGY
- The pharmacokinetics, safety and efficacy of tenofovir and emtricitabine in HIV-1-infected pregnant women
- (2012) Angela P.H. Colbers et al. AIDS
- Cobicistat Boosts the Intestinal Absorption of Transport Substrates, Including HIV Protease Inhibitors and GS-7340,In Vitro
- (2012) Eve-Irene Lepist et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Morphologic changes in the placentas of HIV-positive women and their association with degree of immune suppression
- (2012) Anine Vermaak et al. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
- Protein Binding of Lopinavir and Ritonavir During 4 Phases of Pregnancy
- (2012) Kristine B. Patterson et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Pharmacotherapy in pregnancy; effect of ABC and SLC transporters on drug transport across the placenta and fetal drug exposure
- (2012) Frantisek Staud et al. JOURNAL OF DRUG TARGETING
- Placental Hofbauer cells limit HIV-1 replication and potentially offset mother to child transmission (MTCT) by induction of immunoregulatory cytokines
- (2012) Erica L Johnson et al. Retrovirology
- Synchronized Activity of Organic Cation Transporter 3 (Oct3/Slc22a3) and Multidrug and Toxin Extrusion 1 (Mate1/Slc47a1) Transporter in Transplacental Passage of MPP+ in Rat
- (2012) Davoud Ahmadimoghaddam et al. TOXICOLOGICAL SCIENCES
- Association of recent HIV infection and in-utero HIV-1 transmission
- (2011) Taha E. Taha et al. AIDS
- Pregnancy-Related Effects on Lamivudine Pharmacokinetics in a Population Study with 228 Women
- (2011) Sihem Benaboud et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics of antiretroviral drugs in anatomical sanctuary sites: the fetal compartment (placenta and amniotic fluid)
- (2011) Laura J Else et al. ANTIVIRAL THERAPY
- The Spectrum of Engagement in HIV Care and its Relevance to Test-and-Treat Strategies for Prevention of HIV Infection
- (2011) E. M. Gardner et al. CLINICAL INFECTIOUS DISEASES
- Atazanavir in pregnancy: impact on neonatal hyperbilirubinemia
- (2011) Laurent Mandelbrot et al. European Journal of Obstetrics & Gynecology and Reproductive Biology
- Host factors that influence mother-to-child transmission of HIV-1: genetics, coinfections, behavior and nutrition
- (2011) Sascha R Ellington et al. Future Virology
- Safety and exposure of once-daily ritonavir-boosted atazanavir in HIV-infected pregnant women
- (2011) F Conradie et al. HIV MEDICINE
- Effects of in utero antiretroviral exposure on mitochondrial DNA levels, mitochondrial function and oxidative stress
- (2011) AC Ross et al. HIV MEDICINE
- In utero and intra-partum HIV-1 transmission and acute HIV-1 infection during pregnancy: using the BED capture enzyme-immunoassay as a surrogate marker for acute infection
- (2011) E. T. Marinda et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Atazanavir Pharmacokinetics With and Without Tenofovir During Pregnancy
- (2011) Mark Mirochnick et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Efavirenz Pharmacokinetics During the Third Trimester of Pregnancy and Postpartum
- (2011) Tim R. Cressey et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Differential Transmission of HIV Traversing Fetal Oral/Intestinal Epithelia and Adult Oral Epithelia
- (2011) S. M. Tugizov et al. JOURNAL OF VIROLOGY
- Pharmacokinetics and Disposition of Rilpivirine (TMC278) Nanosuspension as a Long-Acting Injectable Antiretroviral Formulation
- (2010) G. van 't Klooster et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Interaction Potential of Etravirine with Drug Transporters AssessedIn Vitro
- (2010) Nadine Cécile Luise Zembruski et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Human trophoblast cells express CD4 and are permissive for productive infection with HIV-1
- (2010) F. J. E. DAVID et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Pharmacokinetic Interactions between Etravirine and Non-Antiretroviral Drugs
- (2010) Thomas N. Kakuda et al. CLINICAL PHARMACOKINETICS
- Fetoprotective activity of breast cancer resistance protein (BCRP, ABCG2): expression and function throughout pregnancy
- (2010) Lenka Hahnova-Cygalova et al. DRUG METABOLISM REVIEWS
- Protease inhibitors atazanavir, lopinavir and ritonavir are potent blockers, but poor substrates, of ABC transporters in a broad panel of ABC transporter-overexpressing cell lines
- (2010) W. F. W. Bierman et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Genital Tract, Cord Blood, and Amniotic Fluid Exposures of Seven Antiretroviral Drugs during and after Pregnancy in Human Immunodeficiency Virus Type 1-Infected Women
- (2009) R. F. Yeh et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- HIV reservoirs, latency, and reactivation: Prospects for eradication
- (2009) Viktor Dahl et al. ANTIVIRAL RESEARCH
- P-Glycoprotein Mediates Efflux Transport of Darunavir in Human Intestinal Caco-2 and ABCB1 Gene-Transfected Renal LLC-PK1 Cell Lines
- (2009) Hiromi Fujimoto et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Drug transporters in the human blood-placental barrier
- (2009) Kirsi Vähäkangas et al. BRITISH JOURNAL OF PHARMACOLOGY
- Clinical Pharmacokinetics and Pharmacodynamics of Etravirine
- (2009) Monika Schöller-Gyüre et al. CLINICAL PHARMACOKINETICS
- Variation of Drug Kinetics in Pregnancy
- (2009) Petr Pavek et al. CURRENT DRUG METABOLISM
- Transplacental Transfer of Antiretroviral Drugs and Newborn Birth Weight in HIV-Infected Pregnant Women
- (2009) Jelena Ivanovic et al. CURRENT HIV RESEARCH
- Nucleoside Transporter Proteins
- (2009) Miriam Molina-Arcas et al. Current Vascular Pharmacology
- Lopinavir protein binding in HIV-1-infected pregnant women
- (2009) FT Aweeka et al. HIV MEDICINE
- Transport of Lamivudine [(-)- -L-2',3'-Dideoxy-3'-thiacytidine] and High-Affinity Interaction of Nucleoside Reverse Transcriptase Inhibitors with Human Organic Cation Transporters 1, 2, and 3
- (2009) G. Minuesa et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- The complexities of antiretroviral drug–drug interactions: role of ABC and SLC transporters
- (2009) Olena Kis et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Population Pharmacokinetics of Emtricitabine in Human Immunodeficiency Virus Type 1-Infected Pregnant Women and Their Neonates
- (2008) D. Hirt et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Inhibition of placental P-glycoprotein: impact on indinavir transfer to the foetus
- (2008) Sreeja Sudhakaran et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Lopinavir Exposure With an Increased Dose During Pregnancy
- (2008) Mark Mirochnick et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Role of placenta in the vertical transmission of human immunodeficiency virus
- (2008) A M Al-husaini Journal of Perinatology
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started